Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Erste Group Bank price target raised to EUR 28 from EUR 25 at JPMorgan » 11:58
01/20/21
01/20
11:58
01/20/21
11:58
EBKDY

Erste Group Bank

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

JPMorgan analyst Samuel Goodacre raised the firm's price target on Erste Group Bank to EUR 28 from EUR 25 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
EBKDY Erste Group Bank
$0.00 /

+ (+0.00%)

01/11/21 UBS
Erste Group Bank price target raised to EUR 29 from EUR 23 at UBS
10/29/20 UBS
Erste Group Bank price target lowered to EUR 23 from EUR 24.80 at UBS
10/23/20 Societe Generale
Erste Group Bank price target lowered to EUR 25 from EUR 26 at Societe Generale
10/21/20 Citi
Erste Group Bank price target lowered to EUR 25 from EUR 25.85 at Citi
Hot Stocks
Haemonetics acquires Cardiva Medical for over $475M » 06:50
01/20/21
01/20
06:50
01/20/21
06:50
HAE

Haemonetics

$128.35 /

+2.59 (+2.06%)

, MC

Moelis

$55.02 /

-0.17 (-0.31%)

, JPM

JPMorgan

$138.00 /

-0.84 (-0.61%)

Haemonetics announced…

Haemonetics announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an upfront cash payment of $475M at closing and up to an additional $35M in contingent consideration based on sales growth. The acquisition is subject to customary closing conditions and is expected to be completed in the Q1. Cardiva's portfolio includes two catheter-based vascular access site closure devices. The acquisition is expected to deliver about $65M-$75M of revenue in the first fiscal year. The transaction is expected to be dilutive to adjusted net earnings per diluted share by (15c)-(20c) in FY22 and about neutral to adjusted net earnings per diluted share in fiscal year 2023. The acquisition is expected to deliver a rate of return on invested capital of 10% by year five. Haemonetics plans to finance this acquisition through a combination of cash, existing revolving credit facility and an additional $150M term loan. Following this acquisition, the Company debt to EBITDA ratio, as calculated in accordance with the terms set forth in the Company's existing Credit Agreement, is expected to be approximately 3.2. Moelis & Company (MC) is serving as financial advisor to Haemonetics and DLA Piper is serving as legal advisor. Additionally, J.P. Morgan (JPM) Securities is acting as financial advisor to Cardiva and Cooley is serving as legal advisor.

ShowHide Related Items >><<
MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

11/05/20 Barrington
Haemonetics upgraded to Outperform from Market Perform at Barrington
07/01/20 Raymond James
Haemonetics price target lowered to $113 from $125 at Raymond James
05/06/20 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
04/07/20 Raymond James
Haemonetics price target lowered to $130 from $150 at Raymond James
MC Moelis
$55.02 /

-0.17 (-0.31%)

01/07/21 JPMorgan
Moelis upgraded to Neutral on M&A recovery at JPMorgan
01/07/21 JPMorgan
Moelis upgraded to Neutral from Underweight at JPMorgan
01/05/21 UBS
Moelis upgraded to Buy from Neutral at UBS
12/16/20 Seaport Global
Seaport Global starts Moelis at Neutral, cites value focus
JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

01/19/21 DA Davidson
JPMorgan price target raised to $163 from $147 at DA Davidson
01/19/21 Seaport Global
JPMorgan price target raised to $157 from $140 at Seaport Global
01/19/21 RBC Capital
JPMorgan price target raised to $150 from $130 at RBC Capital
01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

  • 28
    Oct
JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

Yesterday
Recommendations
JPMorgan price target raised to $163 from $147 at DA Davidson » 09:25
01/19/21
01/19
09:25
01/19/21
09:25
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

DA Davidson analyst David…

DA Davidson analyst David Konrad raised the firm's price target on JPMorgan to $163 from $147 and keeps a Buy rating on the shares. The company posted "strong" Q4 results thanks to its core earnings and lower reserves along with better than expected card and investment banking revenues, the analyst tells investors in a research note. Konrad adds that JPMorgan's better loan growth and steepening yield curve drove its increased 2021 net interest income guidance.

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/19/21 Seaport Global
JPMorgan price target raised to $157 from $140 at Seaport Global
01/19/21 RBC Capital
JPMorgan price target raised to $150 from $130 at RBC Capital
01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
01/19/21 Barclays
JPMorgan price target raised to $172 from $164 at Barclays
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Recommendations
JPMorgan price target raised to $157 from $140 at Seaport Global » 08:44
01/19/21
01/19
08:44
01/19/21
08:44
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

Seaport Global analyst…

Seaport Global analyst Jim Mitchell raised the firm's price target on JPMorgan to $157 from $140 and keeps a Buy rating on the shares following last week's Q4 results. The analyst increased to reflect the $1.5B 2021 net interest income guidance raise along with an expectation for lower credit costs this year and next.

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/19/21 RBC Capital
JPMorgan price target raised to $150 from $130 at RBC Capital
01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
01/19/21 Barclays
JPMorgan price target raised to $172 from $164 at Barclays
01/18/21 Keefe Bruyette
JPMorgan price target raised to $150 from $135 at Keefe Bruyette
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Recommendations
JPMorgan price target raised to $150 from $130 at RBC Capital » 08:06
01/19/21
01/19
08:06
01/19/21
08:06
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

RBC Capital analyst…

RBC Capital analyst Gerard Cassidy raised the firm's price target on JPMorgan to $150 from $130 and keeps an Outperform rating on the shares after its better than expected Q4 results, driven by higher-than-anticipated revenues and a "significant" loan loss provision benefit. The analyst notes that if the economy continues to expand in 2021, JPMorgan should be able to "rebuild its earnings power".

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
01/19/21 Barclays
JPMorgan price target raised to $172 from $164 at Barclays
01/18/21 Keefe Bruyette
JPMorgan price target raised to $150 from $135 at Keefe Bruyette
01/15/21 Wells Fargo
JPMorgan price target raised to $160 from $150 at Wells Fargo
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Recommendations
JPMorgan price target raised to $150 from $142 at Credit Suisse » 08:00
01/19/21
01/19
08:00
01/19/21
08:00
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

Credit Suisse analyst…

Credit Suisse analyst Susan Roth Katzke raised the firm's price target on JPMorgan to $150 from $142 and keeps an Outperform rating on the shares. The analyst notes that JPMorgan reported fourth quarter earnings of $3.79 per share, well ahead of forecasts, with or without the benefit of loan loss reserve release. Results have set the pace for the banks, with quarterly ROTE at 24% and full year ROTE of 14%, she adds.

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/19/21 Barclays
JPMorgan price target raised to $172 from $164 at Barclays
01/18/21 Keefe Bruyette
JPMorgan price target raised to $150 from $135 at Keefe Bruyette
01/15/21 Wells Fargo
JPMorgan price target raised to $160 from $150 at Wells Fargo
01/11/21 Piper Sandler
JPMorgan price target raised to $150 from $118 at Piper Sandler
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Recommendations
JPMorgan price target raised to $172 from $164 at Barclays » 06:41
01/19/21
01/19
06:41
01/19/21
06:41
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

Barclays analyst Jason…

Barclays analyst Jason Goldberg raised the firm's price target on JPMorgan to $172 from $164 and keeps an Overweight rating on the shares following the company's Q4 results.

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/18/21 Keefe Bruyette
JPMorgan price target raised to $150 from $135 at Keefe Bruyette
01/15/21 Wells Fargo
JPMorgan price target raised to $160 from $150 at Wells Fargo
01/11/21 Piper Sandler
JPMorgan price target raised to $150 from $118 at Piper Sandler
01/07/21
Fly Intel: Top five analyst upgrades
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Monday
Recommendations
JPMorgan price target raised to $150 from $135 at Keefe Bruyette » 18:35
01/18/21
01/18
18:35
01/18/21
18:35
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Brian Kleinhanzl raised the firm's price target on JPMorgan to $150 from $135 and keeps a Market Perform rating on the shares following the company's Q4 results. JPMorgan posted a beat largely on lower provision expense, Kleinhanzl tells investors in a research note.

ShowHide Related Items >><<
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/15/21 Wells Fargo
JPMorgan price target raised to $160 from $150 at Wells Fargo
01/11/21 Piper Sandler
JPMorgan price target raised to $150 from $118 at Piper Sandler
01/07/21
Fly Intel: Top five analyst upgrades
01/07/21 Jefferies
JPMorgan upgraded to Buy with $152 price target at Jefferies
JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

Friday
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:27
01/15/21
01/15
16:27
01/15/21
16:27
JPM

JPMorgan

$138.84 /

-2.31 (-1.64%)

, C

Citi

$64.24 /

-4.79 (-6.94%)

, WFC

Wells Fargo

$32.04 /

-2.72 (-7.83%)

, PNC

PNC Financial

$154.85 /

-4.72 (-2.96%)

, XOM

Exxon Mobil

$47.88 /

-2.43 (-4.83%)

, ACCD

Accolade

$52.34 /

+4.63 (+9.70%)

, SPOT

Spotify

$319.86 /

-22.365 (-6.54%)

, DBVT

DBV Technologies

$5.66 /

+1.92 (+51.34%)

, CRDF

Cardiff Oncology

$13.50 /

-6.19 (-31.44%)

, PRGS

Progress Software

$44.15 /

-4.68 (-9.58%)

, AAPL

Apple

$127.07 /

-1.92 (-1.49%)

, SIRI

Sirius XM

$5.81 /

-0.02 (-0.34%)

, AMZN

Amazon.com

$3,105.13 /

-24.86 (-0.79%)

, TUFN

Tufin

$16.95 /

+1.52 (+9.85%)

Stocks ended a bit of a…

ShowHide Related Items >><<
XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

TUFN Tufin
$16.95 /

+1.52 (+9.85%)

SPOT Spotify
$319.86 /

-22.365 (-6.54%)

SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

PRGS Progress Software
$44.15 /

-4.68 (-9.58%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

DBVT DBV Technologies
$5.66 /

+1.92 (+51.34%)

CRDF Cardiff Oncology
$13.50 /

-6.19 (-31.44%)

C Citi
$64.24 /

-4.79 (-6.94%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

ACCD Accolade
$52.34 /

+4.63 (+9.70%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

01/15/21 Wells Fargo
JPMorgan price target raised to $160 from $150 at Wells Fargo
01/11/21 Piper Sandler
JPMorgan price target raised to $150 from $118 at Piper Sandler
01/07/21
Fly Intel: Top five analyst upgrades
01/07/21 Jefferies
JPMorgan upgraded to Buy with $152 price target at Jefferies
C Citi
$64.24 /

-4.79 (-6.94%)

01/12/21 UBS
UBS downgrades Citizens on revenue headwinds, Wells new top pick
01/11/21 Piper Sandler
Citi price target raised to $85 from $68 at Piper Sandler
01/11/21 BofA
BofA US 1 List changes
01/06/21 Deutsche Bank
Citi price target raised to $58 from $50 at Deutsche Bank
WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

01/11/21 UBS
Wells Fargo upgraded to Buy from Neutral at UBS
01/07/21 Jefferies
Wells Fargo upgraded to Buy with $38 price target at Jefferies
01/07/21 Jefferies
Wells Fargo upgraded to Buy from Hold at Jefferies
PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

01/13/21 Piper Sandler
PNC Financial downgraded to Neutral from Overweight at Piper Sandler
01/11/21 Citi
PNC Financial upgraded to Buy from Neutral at Citi
01/11/21 Citi
PNC Financial upgraded to Buy from Neutral at Citi
01/06/21 Deutsche Bank
PNC Financial price target raised to $157 from $115 at Deutsche Bank
XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

01/14/21 Barclays
Barclays upgrades Exxon to Overweight amidst 'perfect storm'
01/14/21 Barclays
Exxon Mobil upgraded to Overweight from Equal Weight at Barclays
01/13/21
Fly Intel: Top five analyst upgrades
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
ACCD Accolade
$52.34 /

+4.63 (+9.70%)

01/15/21 BTIG
Accolade price target raised to $60 from $55 at BTIG
01/15/21 Baird
Accolade price target raised to $55 from $50 at Baird
01/15/21 Credit Suisse
Accolade upgraded to Outperform from Neutral at Credit Suisse
01/15/21 Credit Suisse
Accolade upgraded to Outperform from Neutral at Credit Suisse
SPOT Spotify
$319.86 /

-22.365 (-6.54%)

01/15/21
Fly Intel: Top five analyst downgrades
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Citi
Spotify downgraded to Sell from Neutral at Citi
01/04/21 Barclays
Spotify assumed with an Overweight at Barclays
DBVT DBV Technologies
$5.66 /

+1.92 (+51.34%)

01/15/21 Citi
DBV Technologies price target raised to $8 from $4 at Citi
01/15/21 H.C. Wainwright
DBV now has 'clear developmental path,' says H.C. Wainwright
11/02/20 Societe Generale
DBV Technologies upgraded to Hold on improved visibility at Societe Generale
11/02/20 Societe Generale
DBV Technologies upgraded to Hold from Sell at Societe Generale
CRDF Cardiff Oncology
$13.50 /

-6.19 (-31.44%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 H.C. Wainwright
Cardiff Oncology initiated with a Buy at H.C. Wainwright
10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
10/08/20
Fly Intel: Top five analyst initiations
PRGS Progress Software
$44.15 /

-4.68 (-9.58%)

08/26/20 Wedbush
Progress Software assumed with an Outperform at Wedbush
06/26/20 Benchmark
Progress Software price target raised to $43 from $39 at Benchmark
01/17/20 Benchmark
Progress Software price target raised to $57 from $49 at Benchmark
AAPL Apple
$127.07 /

-1.92 (-1.49%)

01/15/21 Goldman Sachs
Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating
01/15/21 Loop Capital
Apple price target raised to $155 from $131 at Loop Capital
01/14/21 Barclays
Apple price target raised to $116 from $100 at Barclays
01/12/21 Wells Fargo
Apple price target raised to $155 from $140 at Wells Fargo
SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
12/17/20 Morgan Stanley
Sirius XM price target raised to $7.50 from $6.75 at Morgan Stanley
12/17/20 Morgan Stanley
Liberty SiriusXM price target raised to $52 from $45 at Morgan Stanley
AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

01/11/21 Baird
Baird remains a buyer of Amazon ahead of Q4 results
12/22/20 Wells Fargo
Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
12/14/20 BMO Capital
BMO downgrades Disney after recent run, names new top media pick
TUFN Tufin
$16.95 /

+1.52 (+9.85%)

01/15/21 Barclays
Tufin price target raised to $22 from $13 at Barclays
01/05/21 Piper Sandler
Tufin price target raised to $12 from $9 at Piper Sandler
09/25/20 Baird
Baird starts Tufin at Neutral with $10 price target
09/24/20 Baird
Tufin initiated with a Neutral at Baird
XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

TUFN Tufin
$16.95 /

+1.52 (+9.85%)

SPOT Spotify
$319.86 /

-22.365 (-6.54%)

SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

PRGS Progress Software
$44.15 /

-4.68 (-9.58%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

DBVT DBV Technologies
$5.66 /

+1.92 (+51.34%)

CRDF Cardiff Oncology
$13.50 /

-6.19 (-31.44%)

C Citi
$64.24 /

-4.79 (-6.94%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

ACCD Accolade
$52.34 /

+4.63 (+9.70%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

  • 22
    Oct
  • 30
    Sep
  • 02
    Jul
  • 30
    Jan
XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

SPOT Spotify
$319.86 /

-22.365 (-6.54%)

SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

C Citi
$64.24 /

-4.79 (-6.94%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

ACCD Accolade
$52.34 /

+4.63 (+9.70%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

SPOT Spotify
$319.86 /

-22.365 (-6.54%)

SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

PRGS Progress Software
$44.15 /

-4.68 (-9.58%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

DBVT DBV Technologies
$5.66 /

+1.92 (+51.34%)

CRDF Cardiff Oncology
$13.50 /

-6.19 (-31.44%)

C Citi
$64.24 /

-4.79 (-6.94%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

ACCD Accolade
$52.34 /

+4.63 (+9.70%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

XOM Exxon Mobil
$47.88 /

-2.43 (-4.83%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

SPOT Spotify
$319.86 /

-22.365 (-6.54%)

SIRI Sirius XM
$5.81 /

-0.02 (-0.34%)

PRGS Progress Software
$44.15 /

-4.68 (-9.58%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

JPM JPMorgan
$138.84 /

-2.31 (-1.64%)

CRDF Cardiff Oncology
$13.50 /

-6.19 (-31.44%)

C Citi
$64.24 /

-4.79 (-6.94%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

ACCD Accolade
$52.34 /

+4.63 (+9.70%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

Recommendations
JPMorgan price target raised to $160 from $150 at Wells Fargo » 15:17
01/15/21
01/15
15:17
01/15/21
15:17
JPM

JPMorgan

$139.52 /

-1.63 (-1.15%)

Wells Fargo analyst Mike…

Wells Fargo analyst Mike Mayo raised the firm's price target on JPMorgan to $160 from $150 and keeps an Overweight rating on the shares following this morning's "strong" Q4 results. The analyst increased estimates to reflect higher net interest income than previously modeled given management comments, better credit trends and a lower share count.

ShowHide Related Items >><<
JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

01/11/21 Piper Sandler
JPMorgan price target raised to $150 from $118 at Piper Sandler
01/07/21
Fly Intel: Top five analyst upgrades
01/07/21 Jefferies
JPMorgan upgraded to Buy with $152 price target at Jefferies
01/07/21 BofA
JPMorgan upgraded to Buy from Neutral at BofA
JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

JPM JPMorgan
$139.52 /

-1.63 (-1.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.